Keywords: TME; tumour microenvironment; PD-1; programmed cell death 1; PD-L1; programmed death ligand 1; PD-L2; programmed death ligand 2; PTMs; post-translational histone modifications; DNMTi; DNA methyltransferase inhibitor; HDACi; histone deacetylase inhibitor;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Vitamin C - A new player in regulation of the cancer epigenome
Keywords: 5caC; 5-carboxylcytosine; 5fC; 5-formylcytosine; 5hmC; 5-hydroxymethylcytosine; 5mC; 5-methylcytosine; AML; acute myeloid leukemia; DHA; dehydroascorbic acid; DNMT; DNA methyltransferase; DNMTis; DNA methyltransferase inhibitors; GLUT; glucose transporter
HDAC inhibitors as epigenetic regulators for cancer immunotherapy
Keywords: AICD; activation-induced cell death; AML; acute myeloid leukemia; APC; antigen-presenting cells; CAR; coxsackie- and adenovirus receptor; CDKs; cyclin-dependent kinases; CG; cancer germline; DCs; dendritic cells; HAT; histone acetyltransferase; HDAC; hist
Nucleosidic DNA demethylating epigenetic drugs - A comprehensive review from discovery to clinic
Keywords: ALL; Acute lymphoblastic leukemia; AML; Acute myeloid leukemia; AUC; Area under the curve; AZA; 5-azacytidine; 5-aza-CdR; 2â²-deoxy-5-azacytidine; 5-aza-CR; 5-azacytidine; AZN; Azanucleosides; BED; Biologically effective dose; BSC; Best supportive care;
Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation
Keywords: Epigenetics; Cardiovascular disease; Histone; DNA methyltransferase inhibitors; Histone deacetylase inhibitors;
Inhibition of mitogen-activated protein kinase kinase, DNA methyltransferase, and transforming growth factor-β promotes differentiation of human induced pluripotent stem cells into enterocytes
Keywords: Human induced pluripotent stem cells; Differentiation; Enterocytes; Small-molecule compounds; Mitogen-activated protein kinase kinase inhibitors; DNA methyltransferase inhibitors; Transforming growth factor-β inhibitors; Drug-metabolizing enzyme activity
Immunomodulatory action of SGI-110, a hypomethylating agent, in acute myeloid leukemia cells and xenografts
Keywords: Acute myeloid leukemia; SGI-110; Cancer testis antigens; Epigenetics; DNA methylation; DNA methyltransferase inhibitors; Cancer germline genes; Immune modulation
The Multidisciplinary Approach to Thymoma: Combining Molecular and Clinical Approaches
Keywords: Thymoma; Thymic carcinoma; Classification; Targeted therapy; KIT inhibitors; HDAC inhibitors; VEGF inhibitors; IGF-1R inhibitors; DNA methyltransferase inhibitors; CDK/TRKA inhibitors
In vitro basis for treatment with hypomethylating agents and histone deacetylase inhibitors: can epigenetic changes be used to monitor treatment?
Keywords: DNA methyltransferase inhibitors; Azacitidine; Histone deacetylase inhibitors; Myelodysplastic syndromes treatment; Predictors of response; Cancer epigenetics